EC-US COOPERATION IN INFECTIOUS DISEASES OF ANIMALS · – Develop a transatlantic strategic...
Transcript of EC-US COOPERATION IN INFECTIOUS DISEASES OF ANIMALS · – Develop a transatlantic strategic...
LB Feb 2005 1
EC-US COOPERATION IN INFECTIOUS DISEASES OF ANIMALS
State of ProgressState of Progress
EC-US Task Force meeting 19-20 July 2006
Isabel Mínguez & Laurent Bochereau (EC)Cyril Gay, Ronald Green & Steven Kappes (USDA)
LB Feb 2005 2
Outline- Rationale- Workshop Brussels June 2004- Transatlantic Cooperation on Zoonoses- International Efforts on Avian Influenza- Preparation of the Workshop 2006- Further Cooperation Opportunities
LB Feb 2005 3
Rationale
Infectious diseasesMajor cause of deaths in humansMajor economic losses in domestic animalsMajor cause of wildlife destructionMajor impact on developing countries and poverty
Emerging and re-emerging in the last 20-30 yearsHIV/AIDSMarburg/EbolaDengue, Nipah, HantaSARS, monkey poxBSEFMD, BT, AICholera, AMR
Multiple causes for emerging infectious diseasesdemography, mobility, technological changes, environmental pollution, global warming, ….
LB Feb 2005 4
What is the current status with infectious diseases and what is the future going to hold?Do we know what really cause disease?What is the basis for host-pathogen specificityand why some pathogens cross into otherspecies?What would we need to know to predict the emergence and re-emergence of a disease?What do we need to know to coordinate efforts on these topics between the EC and the US?
EC-US Workshop on Emerging Diseases in Men and Animals (June 2004)
Issues Addressed
LB Feb 2005 5
EC-US Workshop on Emerging Diseases in Men and Animals (June 2004)
Recommendations Scientific Areas
Ecology of infectious diseasesVaccinesDiagnosticsBiosafetySurveillanceModeling
Cross-cutting Issues
InterdisciplinarityInfrastructure
LB Feb 2005 6
EU-US SAFEFOODSpecific Support Action
Objective– Develop a transatlantic strategic alliance between zoonoses
research networks (surveillance, epidemiology, microbial ecology, control/intervention)
Networks: – MED-VET-NET (EC)– FSRRN (USDA-CSREES)
Activities– Workshops– Exchanges– Dissemination
MED-VET-NET16 EU institutes
EU-US SAFEFOOD
FSRRN9 US universities
ARS
LB Feb 2005 7
Expert Scientific Exchange Programme
●●●Expert Scientific Exchange Programme
An opportunity for European scientist working in the area of microbial food safety to visit US laboratories. The Expert Scientific Exchange programme invites up to 20 European foodborne safety scientists from throughout Europe to apply for travel grants to visit research laboratories in the US and Canada in order to ensure technology transfer, and promote collaboration of expertise sharing. The selection of candidates will be based on joint expressed interest between the Med-Vet-Net and FSSRN networks. The programme covers the areas: ‘Epidemiology and risk attribution’, ‘microbial ecology’, ‘detection’ and ‘control and intervention’. Application procedure: 1. Please visit the Food Safety Research & Response Network website (www.fsrrn.net) to identify an FSRRN laboratory and make direct contact with an investigator. 2. Discuss the opportunities for cooperative research and training. 3. Jointly submit and application (please, see the application form for more details). The application should be submitted at least three months prior to the first date of the visit. The duration of an expert scientific exchange visit is not restricted but will normally be 3-14 days. The host institution may be able to provide housing, which would provide the opportunity for the exchange programme to be extended; we strongly encourage applicants to search for such opportunities. Participating institutions in The US and Canada: Contact information of more than 90 researchers in The US and Canada are available at the Food Safety Research & Response Network website (www.fsrrn.net).
LB Feb 2005 8
AI context : evolving epidemiologicalsituation Asian H5N1 crisis
Unprecedented spreadPublic health, Risk of pandemia, Migratory birdsMany unknowns
Needs for – Increase knowledge– Improved diagnostics– Improved/new vaccines– Different control measures– International cooperation
LB Feb 2005 9
A Dedicated Call for Proposals: SSP-5B INFLUENZA
Specific Tasks
1. Sustainable management of Europe’s natural resources (AVIAN INFLUENZA)
New and more environment friendly production methods to improve animal health and welfare including research
on animal diseases (…) and development of marker vaccines
Recommendations of EFSA, FAO, OIE & WHO
Agreed by DG SANCO
Indicative budget: 10 m€
LB Feb 2005 10
A Dedicated Call for Proposals: SSP-5B INFLUENZA
Specific Tasks1. Sustainable management of Europe’s
natural resources (AVIAN INFLUENZA)
New and more environment friendly production methods to improve animal health and welfare including research on animal diseases
(…) and development of marker vaccines
• Influenza vaccine development for avian species (STREP)
• Improved diagnosis and early warning systems (STREP)
• Ecology and pathogenesis of avian influenza infections (STREP)
• Migratory birds (STREP/CA)
• AI virus survival (STREP)
• Reinforcement of the Community and national reference laboratories network for avian influenza (CA)
• Transfer of technology and training particularly for INCO target countries (CA or SSA)
LB Feb 2005 11
European Funding Opportunities
FP7 funding
- Theme 1: Health- Theme 2: Food, Agriculture and Biotechnology
- Sustainable management/production of biological resources=> Wildlife reservoirs of pathogens, Targeted diseases, Neglected zoonoses, - ERC, training/mobility
Relevant Technology Platforms:
Global Animal HealthInnovative Medicines
Standing Committe on Agricultural Research
Working Group on Animal Health
LB Feb 2005 12
Animal Health ResearchMajor Initiatives (1)
Component 1: Biodefense Research– Problem Statement 1A: Foreign Animal Diseases– Problem Statement 1B: Emerging diseases
Component 2: Genetic and Biological Determinants of Disease Susceptibility– Problem Statement 2A: Mastitis– Problem Statement 2B: Avian Tumor Viruses– Problem Statement 2C: Mucosal Diseases of
Livestock and Poultry Component 3: Countermeasures to Prevent and Control Zoonotic Diseases– Problem Statement 3A: Brucellosis– Problem Statement 3B: Leptospirosis– Problem Statement 3C: Tuberculosis
LB Feb 2005 13
Component 4: Countermeasures to Prevent and Control Respiratory Diseases– Problem Statement 4A: Ruminant Respiratory Diseases– Problem Statement 4B: Porcine Respiratory Diseases– Problem Statement 4C: Poultry Respiratory Diseases
Component 5: Countermeasures to Prevent and Control Reproductive and Neonatal Diseases– Problem Statement 5A: Bovine Viral Diarrhea (BVD)– Problem Statement 5B: Neosporosis– Problem Statement 5C: Reproductive Health of the
Dairy CowComponent 6: Countermeasures to Prevent and Control Enteric Diseases– Problem Statement 6A: Johne’s Disease– Problem Statement 6B: Enteric Diseases of Poultry
Animal Health ResearchMajor Initiatives (2)
LB Feb 2005 14
Component 7: Countermeasures to Prevent and Control Parasitic Diseases– Problem Statement 7A: Drug Resistant
Gastrointestinal (GI) Parasitic Diseases– Problem Statement 7B: Hemoparasitic Diseases
Component 8: Countermeasures to Prevent and Control Transmissible Spongiform Encephalopathies– Scrapie– Chronic Wasting Disease (CWD)– Bovine Spongiform Encephalopathy (BSE)
Animal Health ResearchMajor Initiatives (3)
LB Feb 2005 15
EC-US Workshop on Advances in Immunology and Vaccine Discovery
National Animal Disease Center (NADC)Ames, Iowa 12-13 December 2006
Objective: to explore state of the art and researchcooperation opportunities at the interface betweenimmunology and vaccinologyThemes:
– Mechanisms of pathogen immune evasion– Innate immunity– Mucosal immunity– Immunogenetics– Comparative immunology– Genomics
LB Feb 2005 16
Two keynote speakers and two speakers per themeAnimal and human worldsDescription of research approach and explanation how the knowledge might be translated into a viable vaccine paradigm through use of molecular techniques
Approach
For each theme, identify:– Gaps that can addressed by research– Steps that must be taken to adress these gaps
Expected Outcomes
EC-US Workshop on Advances in Immunology and Vaccine Discovery